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ReplicationJapanese encephalitis virus (JEV) is a mosquito-borne RNA virus that belongs to the Flaviviridae family. In this
study, we have examined the effect of cyclosporin A (CsA) on the propagation of JEV. CsA exhibited potent
anti-JEV activity in various mammalian cell lines through the inhibition of CypB. The propagation of JEV was
impaired in the CypB-knockdown cells and this reduction was cancelled by the expression of wild-type but
not of peptidylprolyl cis-trans isomerase (PPIase)-deﬁcient CypB, indicating that PPIase activity of CypB is
critical for JEV propagation. Infection of pseudotype viruses bearing JEV envelope proteins was not impaired
by the knockdown of CypB, suggesting that CypB participates in the replication but not in the entry of JEV.
CypB was colocalized and immunoprecipitated with JEV NS4A in infected cells. These results suggest that
CypB plays a crucial role in the replication of JEV through an interaction with NS4A.atsuura).
l rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
The genus Flavivirus within the family Flaviviridae comprises over
70 viruses, many of which are predominantly arthropodborne viruses,
such as Japanese encephalitis virus (JEV), West Nile virus (WNV),
Murray Valley encephalitis virus, dengue virus (DENV), yellow fever
virus (YFV), and tick-borne encephalitis virus. JEV is one of the most
important ﬂaviviruses in the medical and veterinary ﬁelds and exists
in a zoonotic transmission cycle among mosquitoes, pigs, and birds
mostly in Eastern and Southeast Asia. This virus spreads to dead-end
hosts, including humans, through the bite of JEV-infected mosquitoes,
and around 30,000–50,000 cases and up to 15,000 deaths are reported
annually (Ghosh and Basu, 2009; Mackenzie et al., 2004; Solomon
et al., 2003). JEV has a single-stranded positive-sense RNA genome of
approximately 11 kb, which is capped at the 5′ end but lacks a 3′
polyadenine tail. The genome RNA is translated into a single large
polyprotein at the endoplasmic reticulum (ER) membrane, then
cleaved by the host- and virus-encoded proteases into three structural
proteins, the capsid, precursor membrane (prM), and envelope (E)
proteins, and seven nonstructural (NS) proteins, NS1, NS2A, NS2B,
NS3, NS4A, NS4B, and NS5 (Sumiyoshi et al., 1987).
Flavivirus infection causes extensive rearrangement of cellular
membranes to form two distinct membrane structures called the
vesicle packet and convoluted membrane (Mackenzie et al., 1996;
Miller and Krijnse-Locker, 2008). Whereas the vesicle packet is
believed to contain the replication complex in which viral RNAsynthesis takes place, the convoluted membrane is the putative site
for viral polyprotein processing (Mackenzie et al., 1999). A recent
tomography study clariﬁed that the ER, convoluted membrane, and
outer membrane of the vesicle packet were connected together to
form a continuous membrane, with the vesicle packet being observed
as an invagination of the ER with NS proteins and viral RNA,
suggesting that viral replication occurred on the surface of the ER
(Welsch et al., 2009). The structures of the convoluted membrane can
be observed by infection with the WNV strain Kunjin virus or
expression of the DENV NS4A protein alone (Miller et al., 2007;
Roosendaal et al., 2006). Previous studies have indicated that NS4A
localizes to both the vesicle packet and convoluted membrane and
interacts with NS1, indicating that NS4A plays an important role as an
integral scaffold of the replication complex (Lindenbach and Rice,
1999; Mackenzie et al., 1998).
In addition to NS proteins, ﬂavivirus RNA replication is known to be
regulated by several host factors, such as eEF1A, TIA/TIAR, HMGCR, and
cyclophilin (Cyp) A (Davis et al., 2007; Emara and Brinton, 2007;
Mackenzie et al., 2007; Qing et al., 2009). RNAi screening has identiﬁed
various host factors involved in the replication of RNA viruses, including
the hepatitis C virus (HCV), human immunodeﬁciency virus (HIV), and
inﬂuenza A virus (Karlas et al., 2010; Konig et al., 2010, 2008; Tai et al.,
2009). Host factors essential for viral replicationmight be an ideal target
for antiviral development because the frequency of appearance of
resistant viruses is lower by this method than when using antivirals
targeted to the viral proteins.
In this study, we identiﬁed CypB as a host factor involved in the
propagation of JEV. CypB is a member of the Cyp family, is ubiquitously
expressed in most cells, and predominantly resides in the ER through
the ER retention signal sequence in the C-terminus (Price et al., 1994,
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logical functions, such as chaperone activities, immunosuppression,
transcriptional regulation, apoptosis, and viral propagation (Allain et al.,
1996; Kim et al., 2008; Rycyzyn and Clevenger, 2002; Watanabe et al.,
2010; Watashi et al., 2005; Zhang and Herscovitz, 2003). Cyclosporin A
(CsA), an inhibitor for Cyps, signiﬁcantly impaired the propagation of
JEV. Knockdownof CypB reduced theRNA replication in the JEV replicon
cells, whereas it exhibited no effect on the infection of a pseudotype
virus bearing JEV envelope proteins. Furthermore, CypBwas colocalized
and immunoprecipitated with the JEV NS4A protein. Collectively, these
results suggest that CypB plays a crucial role in the propagation of JEV
through its interaction with NS4A.
Results
CsA suppresses the production of JEV by inhibiting Cyps
CsA is an immunosuppressive agentwidely used in themanagement
of organ transplantation. In addition to this activity, it has been reported
that CsA has potent antiviral effects against HCV (Chatterji et al., 2009;
Kaul et al., 2009; Watashi et al., 2005; Yang et al., 2008), HIV (Franke
et al., 1994; Thali et al., 1994), measles virus (MV) (Watanabe et al.,
2010), inﬂuenza A virus (Liu et al., 2009), vesicular stomatitis virus
(VSV) (Bose et al., 2003), and vaccinia virus (VV) (Castro et al., 2003;
Damaso andMoussatche, 1998). To examine the possibility that CsA has
an antiviral effect on JEV, mammalian cell lines including Huh7, BHK,
and N18 cells were treated with various concentrations of CsA followed
by infection with JEV. At 48 h post-infection, cells were subjected to
immunoblotting. The level of expression of JEV NS1 was signiﬁcantly
decreased by treatmentwith CsA in a dose-dependentmanner in all the
cell lines examined (Fig. 1A). Furthermore, infectious particle produc-
tion in the culture supernatant was also reduced by the treatment with
CsA under the conditions employed without exhibiting any serious
cytotoxic effect (Fig. 1B).Fig. 1. Effect of CsA on the propagation of JEV in mammalian cells. (A) JEV was inoculated at
washed with 10% FBS DMEM and treated with the indicated concentrations of CsA in 10% FBS
actin were detected by immunoblotting. (B) The production of infectious JEV in the culture su
Cell viability was determined at 48 h post-incubation of CsA. The results are representativeCsA exhibits three distinct inhibitory activities on, respectively, the
calcineurin NF-AT signaling pathway, the peptidylprolyl cis-trans
isomerase (PPIase) activity of Cyps, and the transport activity of
p-glycoprotein (Silverman et al., 1997). To determine the antiviral
activity of CsA, we used CsA derivatives and FK506, an immunosup-
pressant structurally different from CsA. cyclosporin D (CsD) has
almost no effect on the calcineurin pathway (Sadeg et al., 1993) and
cyclosporin H (CsH) has a speciﬁc inhibitory activity on the p-
glycoprotein (Silverman et al., 1997). FK506 also inhibits the
calcineurin NF-AT signaling pathway (Almawi and Melemedjian,
2000). Huh7 cells were infected with JEV and treated with various
concentrations of the compounds at 1 h post-infection. The cells and
culture supernatants were harvested at 48 h after treatment and the
expression of JEV NS1 and infectivity were determined, respectively
(Fig. 2). Treatment with CsA and CsD reduced the expression of the
NS1 and the production of JEV in a dose-dependent manner, whereas
CsH and FK506 exhibited almost no effect on the propagation of JEV
(Fig. 2). These results suggest that CsA inhibits JEV propagation
through the inhibition of Cyps, but not through the inhibition of
calcineurin and p-glycoprotein.
CypB participates in the propagation of JEV
Cyps possessing the PPIase activity are highly conserved and
ubiquitously expressed in both prokaryotic and eukaryotic cells
(Wang and Heitman, 2005). Next, to determine whether the particular
Cyp isoform participates in the propagation of JEV, short interference
RNAs (siRNAs) targeted to CypA, CypB, or CypC were transfected into
Huh7 cells and the expression of each Cyp was determined by
immunoblotting or real-time PCR at 24 h post-transfection. CypA and
CypB were speciﬁcally decreased by the transfection of the siRNAs
(Fig. 3A). Although CypC could not be detected by immunoblotting due
to the lack of a speciﬁc antibody in our laboratory, CypC mRNA was
decreased by approximately 90% upon transfectionwith siRNA targetedan MOI of 0.1 (Huh7 and BHK cells) or 10 (N18 cells) and incubated for 1 h. Cells were
DMEM for 48 h. The propagation of JEV was assessed by the expression of NS1. NS1 and
pernatant at 48 h post-infection was determined in Vero cells by a focus-forming assay.
of three independent assays, with the error bars indicating the standard deviations.
Fig. 2. CsA inhibits JEV propagation through the inhibition of Cyps. Huh7 cells were
infectedwith JEV at anMOI of 0.1 for 1 h and then treatedwith 10% FBS DMEMcontaining
the indicated concentrations of CsA, CsD, CsH, or FK506 for 48 h. The propagation of JEV
was evaluated by immunoblotting (A) and focus-forming assay (B). The results are
representative of three independent assays, with the error bars indicating the standard
deviations. Asterisks indicate signiﬁcant differences (*Pb0.01).
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siRNA (Fig. 3B). JEVwas inoculated into cells transfectedwith the siRNA
at 48 h post-transfection and the cells and culture supernatants were
harvested at 48 h post-infection. Expression of JEV NS1 was most
effectively decreased by the knockdown of CypB, followed by CypC, and
knockdown of CypA resulted in a marginal reduction of NS1 expression
compared to the control siRNA (Fig. 3C). Furthermore, the production of
JEV was also effectively suppressed in cells with knockdown of CypB,
followed by those with knockdown of CypC and CypA (Fig. 3D). These
results suggest that CypB plays an important role in the propagation of
JEV. To further conﬁrm the effect CypB on the propagation of JEV, we
established stable knockdown cell lines expressing a short hairpin RNA
(shRNA) targeted to CypB. Consistent with the data from transient
knockdown experiments, both expression of NS1 and virus production
were signiﬁcantly reduced in theCypB-knockdown cell lines (Bose et al.,
2003; Castro et al., 2003) in accordance with the reduction of CypB
(Fig. 4A andB). Therewasno signiﬁcant difference in cell growth among
the cell lines (Fig. 4C).
PPIase activity of CypB is crucial for the propagation of JEV
The PPIase activity of Cyps is suggested to catalyze the proper
folding of certain proteins (Andreotti, 2003; Wang and Heitman,
2005). It has been demonstrated that PPIase activity of Cyps isrequired for HCV replication (Chatterji et al., 2009; Kaul et al., 2009;
Watashi et al., 2005). To examine the effect of the PPIase activity of
CypB on the propagation of JEV, we constructed an expression
plasmid encoding a PPIase-defective CypB in which the Arg62 was
replaced with Ala, because the Arg62 in CypB has been shown to be
critical for PPIase catalytic activity (Carpentier et al., 1999). Each of the
expression plasmids encoding the FLAG-tagged wild- or Ala62-CypB
carrying the silent mutations resistant to the siRNA was introduced
into the stable CypB-knockdown cell line (Bose et al., 2003) and
cultured for a week in the presence of neomycin. Although expression
of both endogenous and exogenous CypB was detected at a similar
level (Fig. 4D), JEV production was partially rescued by introducing
the wild-CypB but not the Ala62-CypB (Fig. 4E). These results indicate
that the PPIase activity of CypB is crucial for the propagation of JEV.
CypB participates in the replication but not in the entry of JEV
To further examine the effect of CsA on the JEV life cycle, we
generated a subgenomic replicon of JEV to assess the effect of CsA on
the JEV RNA replication (Fig. 5A). The replicon cells treated with CsA
for 6 days exhibited a signiﬁcant reduction of NS1 expression
compared to the non-treated cells (Fig. 5B). The replicon RNA
transcribed from the pJErepIRESpuro was transfected into the stable
CypB-knockdown (#4) or control cell lines and incubated for 3 weeks
in the presence of puromycin. A few colony formation was detected in
the CypB-knockdown cell line, in contrast to the abundant colony
formation in the control cell line (Fig. 5C). These results suggest that
CypB is required for the efﬁcient replication of JEV.
Next, to examine the impact of CypB on the entry of JEV, we
generated pseudotype VSVs bearing envelope proteins of JEV (JEVpv)
or VSV (VSVpv). Because these viruses possess the luciferase gene, the
infectivity can be assessed by the luciferase activity (Tani et al., 2010).
Huh7 cells pretreated with various concentrations of CsA were
infected with JEVpv or VSVpv, and the infectivity was assessed by
the expression of luciferase. There was no signiﬁcant effect of CsA on
the infection of either pseudotype virus (Fig. 5D). Similarly, no effect
was observed on the infection of the pseudotype viruses in the CypB-
knockdown cell lines (Fig. 5E). Collectively, these results clearly
indicate that CypB participates in the replication but not in the entry
of JEV.
CypB interacts with the JEV NS4A protein
Many viruses have been shown to utilize Cyps through the
interaction with their viral proteins. For example, HCV recruits CypA
and CypB to enhance viral RNA replication through the interaction
with NS5A and NS5B, respectively (Chatterji et al., 2009; Kaul et al.,
2009; Watashi et al., 2005; Yang et al., 2008). To determine whether
the JEV proteins interact with CypB, we prepared expression plasmids
encoding each of the JEV nonstructural proteins involved in the viral
RNA replication. FLAG-tagged CypBwas co-expressedwith each of the
HA-tagged JEV nonstructural proteins in 293T cells and immunopre-
cipitated with anti-HA antibody. The precipitates were subjected to
immunoblotting by using either anti-FLAG or anti-HA antibodies.
CypB was co-precipitated with the JEV NS4A protein but not with
other proteins (Fig. 6A). Furthermore, interaction of CypB with NS4A
was reduced in the immunoprecipitation analysis in the presence of
CsA (Fig. 6B). To gain more insight into the interaction between CypB
and NS4A, the intracellular localization of these proteins was
examined by confocal microscopy. Huh7 cells were transfected with
an expression plasmid encoding HA-tagged NS4A or an empty vector
and ﬁxed at 48 h post-transfection. Endogenous CypB was detected
in the perinuclear region together with NS4A protein. In addition,
NS4A colocalized with ER marker protein, calnexin (Fig. 6C). These
results suggest that NS4A protein interacts with CypB at the
replication complex localized in the ER.
Fig. 3. CypB plays an important role in the propagation of JEV. (A) Knockdown of endogenous CypA and CypB by siRNA. Huh7 cells were transfected with 35 nM of siRNA targeted to
CypA, CypB, or a non-speciﬁc control. Cell lysates after 96 h post-transfection were analyzed for expression of CypA, CypB, or actin by immunoblotting. (B) Huh7 cells transfected
with 35 nM of siRNA targeted to CypC or a non-speciﬁc control were harvested at 24 h post-transfection. CypCmRNA levels were determined by quantitative real-time PCR. The level
of CypC mRNA was normalized to the amount of GAPDH mRNA and expressed as a percentage of the control value. (C, D) Huh7 cells were transfected with siRNA targeted to CypA,
CypB, or CypC and infected with JEV at an MOI of 0.1 at 48 h post-transfection. The propagation of JEV was determined by immunoblotting (C) and focus-forming assay (D). The
results are representative of three independent assays, with the error bars indicating the standard deviations. Asterisks indicate signiﬁcant differences (*Pb0.01; **Pb0.05).
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In this study, we have shown that CsA inhibits the replication of
JEV through the inhibition of the PPIase activity of Cyps. A previous
study showed that CsA does not induce interferon in Huh7 cells
(Nakagawa et al., 2005), suggesting that the antiviral activity of CsA
on the propagation of JEV relies on the inhibition of Cyps. Cyps are
highly conserved PPIases that catalyze the cis-trans isomerization of
peptide bonds to facilitate certain protein foldings (Andreotti, 2003;
Wang and Heitman, 2005) and are involved in the correct folding of
host and viral proteins. Among the Cyp isoforms, CypA and CypB are
the most abundantly expressed in cells and play key roles in the
propagation of various viruses. CypA is incorporated into HIV,
inﬂuenza A virus, VSV, and VV to regulate their replication (Bose
et al., 2003; Castro et al., 2003; Damaso andMoussatche, 1998; Franke
et al., 1994; Liu et al., 2009; Thali et al., 1994). CypB is incorporated
into MV particles to facilitate an efﬁcient infection (Watanabe et al.,
2010). Both CypA and CypB have been shown to serve as host factors
involved in the replication of HCV through the interaction with NS5A
and NS5B (Chatterji et al., 2009; Kaul et al., 2009;Watashi et al., 2005;
Yang et al., 2008).
Recently, Qing et al. reported that CypA plays an important role in
the replication of ﬂaviviruses such asWNV, YFV, and DENV. The PPIase
activity of CypA was shown to be crucial for the efﬁcient replication of
the viruses, indicating that CypA acts as a molecular chaperone for the
viral and host proteins required for an effective RNA replication (Qing
et al., 2009). Indeed, knockdown of CypA suppressed the JEV
propagation in this study, but that of CypB exhibited more potent
impairment of the JEV propagation, suggesting that CypB plays a
crucial role in the propagation of JEV. However, we could not exclude
the possibility of the involvement of other Cyps in the replication ofJEV. Multiple Cyps have been shown to involved in the life cycle of
HCV (Gaither et al., 2010; Nakagawa et al., 2005) and the knockdown
experiment of Cyps in this study suggests that not only CypB, but also
CypC and CypA are involved in the propagation of JEV. At least 16 Cyps
have been shown to participate in various cellular functions in
humans (Wang and Heitman, 2005), and therefore, further studies to
clarify the precise function of these Cyps in the life cycle of the
ﬂaviviruses are needed.
In addition to Cyps, ﬂavivirus recruits several host chaperones for
an efﬁcient propagation. HSP70 and HSP90 have been identiﬁed as
comprising the DENV receptor complex in human cell lines. These
chaperones presumably facilitate the viral envelope dimer–trimer
transition after the binding of the envelope protein to the cellular
receptor (Reyes-Del Valle et al., 2005). Moreover, inhibition of the
interaction between the ER chaperone calnexin and JEV glycoproteins
has been suggested to affect the folding of viral proteins, leading to a
reduction in the mortality rate in a mouse model of lethal infection
(Wu et al., 2002). It has been reported that ER chaperones including
BiP, calnexin, and calreticulin interact with the DENV envelope
protein, and that knockdown of these chaperones decreased viral
production (Limjindaporn et al., 2009). In addition, BiP was shown to
be upregulated in cells infected with DENV to facilitate viral
production (Wati et al., 2009), and BiP and calreticulin have been
associated with CypB (Zhang and Herscovitz, 2003). Therefore, these
ER resident chaperones are considered to play important roles in the
ﬂavivirus replication through the proper folding of the viral and host
proteins making up the viral RNA replication complex.
Lackof recovery of JEVpropagation in theCypB-knockdowncell lines
by the expression of the PPIase-deﬁcient CypB mutant suggests that
PPIase activity is crucial for the JEV production. Although the PPIase
activity of CypA has been shown to be required for ﬂavivirus replication
Fig. 4. PPIase activity of CypB is crucial for the propagation of JEV. Huh7 cell lines expressing shRNA targeted to CypB or the control were infectedwith JEV at anMOI of 0.1 for 1 h and
cultured in 10% FBS DMEM for 48 h. The expressions of NS1, CypB, and actin were detected by immunoblotting (A). The propagation of JEV was determined by focus-forming assay
(B). Growth kinetics of the stable CypB-knockdown cell lines were determined by the method of trypan blue dye exclusion (C). The stably knocked-down cell lines were transfected
with the siRNA-resistant FLAG-tagged wild- or Ala62-CypB, or empty vector and cultured for 1 week in the presence of 1 μg/ml puromycin. The remaining cells were infected with JEV
at anMOI of 1. The expressions of NS1, CypA, endogenous and exogenous CypBs, and actin were detected by immunoblotting (D). Virus production in the culture supernatant at 36 h
post-infection was determined by a focus-forming assay (E). The results are representative of three independent assays, with the error bars indicating the standard deviations.
Asterisks indicate signiﬁcant differences (*Pb0.01).
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CypB was colocalized and speciﬁcally co-immunoprecipitated with JEV
NS4A. CypA is abundantly expressed in the cytoplasm of mammalian
cells (Galigniana et al., 2004) and NS5 is predominantly detected on the
cytoplasmic side of the ER (Zhang et al., 1992). Thus, it is conceivable
that an interaction between CypA and NS5 occurs on the cytoplasmic
side of the ER. On the other hand, CypB is localized in the ER lumen and
targeted to the secretory pathway via its ER signal sequence (Price et al.,
1994, 1991). NS4A is predicted to be a three-transmembrane protein
with its C-terminal end localized in the ER lumen (Miller et al., 2007).
Therefore, it is plausible that CypB interacts with NS4A within the ER
lumen and confers proper folding to form the RNA replication complex
of JEV. Expression of DENV NS4A alone has been shown to induce
rearrangement of the cytoplasmic membrane to form the convoluted
membrane required for viral replication (Roosendaal et al., 2006). It
might be feasible to speculate that JEV NS4A undergoes conformational
change through the interactionwith CypB and induces formation of the
convolutedmembrane in the ER essential for genome replication of JEV.
It was reported that HCV NS5A from CsA resistant mutant exhibits an
enhanced interaction with CypB and NS5B facilitates a stronger binding
of the mutant NS5A to endogenous CypB than wild-type in cell culture
(Fernandes et al., 2010). Study of the molecular mechanism underlying
the CsA resistant of JEV may shed light on the complex interaction
among Cyps and viral proteins.
In conclusion, we have demonstrated that CsA suppresses the
propagation of JEV by inhibiting the interaction between CypB and
NS4A, which is required for viral RNA replication. Further studies are
needed to elucidate the precise molecular mechanism underlying the
involvement of cellular Cyps in the efﬁcient propagation of JEV. Three
inhibitors of the PPIase activity of Cyps, DEBIO-025, SCY635, andNIM811, are currently under clinical trial for the treatment of hepatitis
C patients (Puyang et al., 2010). The PPIase inhibitor may be an
attractive therapeutic target for the treatment of patients infected
with not only HCV but also other ﬂaviviruses.
Materials and methods
Plasmids
The human CypB gene was ampliﬁed from the total cDNA of Huh7
by PCR using LA taq (Takara Bio Inc., Shiga, Japan) and cloned into
pcDNA3.1 and pCAGPM (Mori et al., 2007). The plasmids encoding the
NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5 of the JEV AT31 strain
were generated by PCR and cloned into pCAGPM. The pSilencer-CypB,
carrying an shRNA targeted to CypB under the control of the U6
promoter, was constructed by cloning of the oligonucleotide pair 5′-
GATCCGGTGGAGAGCACCAAGACATTCAAGAGATGTCTTGGTGCTCTC-
CACCTTTTTTGGAAA-3′-5′-AGCTTTTCCAAAAAAGGTGGAGAGCACCAA-
GACATCTCTTGAATGTCTTGGTGCTCTCCACCG-3′ between the BamHI
and HindIII sites of pSilencer 2.1-U6 hygro (Ambion, Austin, TX). A
plasmid coding a mutant CypB resistant to shRNA was prepared by
insertion of four silent mutations (the nucleotides at positions 543,
549, 555, and 561 were changed from G to A, G to A, C to G, and A to C,
respectively) into CypB cDNA by the method of splicing by overlap
extension (Ho et al., 1989). The pSilencer negative-control plasmid
(Ambion) has no homology to any human gene. The pJErep plasmid
was kindly provided by Dr. Konishi (Kobe University, Kobe, Japan). A
puromycin-resistant gene under the internal ribosomal entry site
(IRES) of encephalomyocarditis virus was inserted into pJErep and
designated as pJErepIRESpuro.
Fig. 5. CypB participates in the replication but not in the entry of JEV. (A) Schematic representations of the JEV genome and its subgenomic replicon. (B) JEV replicon cells were
treated with CsA (1 μg/ml) for 6 days, and the expressions of NS1 and actin were detected by immunoblotting. (C) The stable CypB-knockdown and control cell lines were
electroporated with the JEV replicon RNA and cultured for 3 weeks in the presence of 1 μg/ml of puromycin. The remaining cells were ﬁxed with 4% paraformaldehyde and stained
with crystal violet. (D) Huh7 cells treated with the indicated concentrations of CsA for 1 h were infectedwith the pseudotype viruses, JEVpv and VSVpv, and luciferase activities were
determined at 24 h post-infection. (E) The stable CypB-knockdown and control cell lines were incubated with the pseudotype viruses, and the luciferase activities were determined.
The results shown are representative of three independent assays, with error bars indicating standard deviations.
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All cell lines were cultured at 37 °C under the condition of a
humidiﬁed atmosphere and 5% CO2. The human embryonic kidney
cell line, 293T, African green monkey kidney cell line, Vero,
hepatocellular carcinoma cell line, Huh7, mouse neural cell line,
N18, and baby hamster kidney cell line, BHK, were maintained in
Dulbecco's modiﬁed Eagle's medium (DMEM) (Sigma, St. Louis, MO)
supplemented with 100 U/ml penicillin, 100 μg/ml streptomycin,
non-essential amino acid (Sigma), and 10% fetal bovine serum
(FBS). The mosquito C6/36 cell line (Aedes albopictus) was cultured
at 27 °C and maintained in modiﬁed Eagle's medium (MEM)
(Sigma). Huh7 cells were transfected with pSilencer-CypB or control
plasmid and drug-resistant clones were selected by treatment with
hygromycin B (Wako, Tokyo, Japan) at a ﬁnal concentration of
50 μg/ml. Huh7 cells were electroporated with in vitro-transcribed
RNA from pJErepIRESpuro and drug-resistant clones were selected
by treatment with puromycin (InvivoGen, San Diego, CA) at a ﬁnal
concentration of 1 μg/ml. Wild-type JEV strain AT31 was used as
described previously (Tani et al., 2010). The wild-type JEV was
ampliﬁed on C6/36 cells and stored at −80 °C. Pseudotype VSVs
bearing JEV PrM and E proteins (JEVpv) and VSVG (VSVpv) were
produced in 293T cells transfected with pCAG105E and pCAGVSVG,
respectively, as described previously (Tani et al., 2010). TheFig. 6.NS4A protein recruits CypB to the replication complex in the JEV-infected cells. (A) FLA
NS5 in 293T cells and immunoprecipitated with anti-HA antibody. The immunoprecipitat
(B) FLAG-tagged CypB was co-expressed with HA-tagged NS4A in 293T cells. The cell lysates
FLAG antibody. The immunoprecipitates were subjected to immunoblotting by using either
encoding HA-tagged NS4A or empty vector were ﬁxed at 48 h post-transfection, permeabiliz
(red). Cell nuclei were stained with DAPI (blue). Intracellular localization of CypB and NS4infectivities of JEV and the pseudotype VSVs were assessed by
both a focus-forming assay and luciferase activity as described
previously (Tani et al., 2010). Cell viability was determined by using
CellTiter-Glo (Promega Corporation, Madison, WI) according to the
manufacturer's protocol.
Reagents and antibodies
CsA and FK506 were purchased from Sigma, and CsD and CsH from
Eton Bioscience Inc. (San Diego, CA). Mouse monoclonal antibodies to
tags of HA and FLAG and β-actin were previously described (Taguwa
et al., 2009). Rabbit polyclonal antibodies to CypA and CypB were
purchased from Upstate Cell Signaling (Lake Placid, NY) and Afﬁnity
BioReagents (Golden, CO), respectively. Rabbit polyclonal antibody to
calnexin was purchased from Santa Cruz Biotechnology (Santa Cruz,
CA). Mouse monoclonal antibody to JEV NS1 protein (34A1) was kindly
provided by Dr. Yasui.
Transfection, immunoblotting, and immunoprecipitation
Transfection and immunoprecipitationwere carriedout asdescribed
previously (Taguwa et al., 2009). Immunoprecipitates boiled in loading
buffer were subjected to 12.5% sodium dodecyl sulfate-polyacrylamide
gel electrophoresis. The proteins were transferred to polyvinylideneG-tagged CypBwas co-expressed with HA-tagged NS1, NS2A, NS2B, NS3, NS4A, NS4B, or
es were subjected to immunoblotting by using either anti-FLAG or anti-HA antibody.
obtained after lysis with the buffer containing CsA were immunoprecipitated with anti-
anti-FLAG or anti-HA antibody. (C) Huh7 cells transfected with an expression plasmid
ed, and stained with the appropriate antibodies to HA (green), calnexin (red), and CypB
A was examined by confocal microscopy.
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218 H. Kambara et al. / Virology 412 (2011) 211–219diﬂuoride membranes (Millipore, Bedford, MA) and were reacted with
the appropriate antibodies. The immune complexes were visualized
with Super Signal West Femto substrate (Pierce, Rockford, IL) and
detected by an LAS-3000 image analyzer system (Fujiﬁlm, Tokyo,
Japan).Gene silencing by siRNA
The siRNAs against CypA and CypBwere 5′-AAGCATACGGGTCCTGG-
CATC-3′ and5′-AAGGTGGAGAGCACCAAGACA-3′, respectively (QIAGEN,
Tokyo, Japan). FlexTube siRNAs against CypC and the negative control
were purchased from QIAGEN. The cells were grown on 6-well plates
and transfected with 35 nM siRNA by using Dharmafect (Dharmacon,
Buckinghamshire, UK) according to the manufacturer's protocol. The
transfected cells were incubated in DMEM supplemented with 10% FBS.Quantitative RT-PCR
RNA was determined by the method described previously (Taguwa
et al., 2009). The total RNAwas prepared from cells by using an RNeasy
mini kit (QIAGEN). First-strand cDNAwas synthesized using an RNA LA
PCR™ in vitro cloning kit (Takara Bio Inc.) and random primers. Each
cDNA was determined by Platinum SYBR Green qPCR SuperMix UDG
(Invitrogen, San Diego, CA) according to the manufacturer's protocol.
Fluorescent signals were analyzed by an ABI PRISM 7000 (Applied
Biosystems, Tokyo, Japan).In vitro transcription and RNA transfection
Plasmid pJErepIRESpuro linearized at the Swa I site was tran-
scribed in vitro using an mMESSAGE mMACHINE (Ambion) according
to the manufacturer's protocol. The in vitro-transcribed RNA was
introduced into Huh7 cells at 5 million cells/0.5 ml by electroporation
at 270 V and 960 μF using Gene Pulser™ (Bio-rad, Hercules, CA).Colony formation assay
Colony formation was determined as previously described
(Taguwa et al., 2009). Brieﬂy, in vitro-transcribed RNA was electro-
porated into Huh7 cells and plated on DMEM containing 10% FBS and
non-essential amino acids. The medium was replaced with fresh
DMEM containing 10% FBS, non-essential amino acids, and 1 μg/ml
puromycin at 24 h post-transfection. The remaining colonies were
ﬁxed with 4% paraformaldehyde (PFA) and stained with crystal violet
at 3 weeks after electroporation.Indirect immunoﬂuorescence assay
Cells cultured on glass slides were ﬁxed with 4% PFA in phosphate
buffered saline (PBS) at room temperature for 30 min. After washing
three times with PBS, the cells were permeabilized for 20 min at room
temperature with PBS containing 0.25% saponin and blocked with
phosphate buffer containing 2% BSA for 1 h at room temperature. The
cells were incubated with blocking buffer containing mouse anti-HA
or rabbit anti-CypB at room temperature for 1 h, then washed three
times with PBS and incubated with blocking buffer containing AF488-
conjugated anti-mouse IgG and AF594-conjugated anti-rabbit IgG at
room temperature for 1 h. Cell nuclei were stained blue with DAPI.
Finally, the cells were washed three times with PBS and observed a
FluoView FV1000 laser scanning confocal microscope (Olympus,
Tokyo, Japan).Statistical analysis
Results are expressed as the means±standard deviation. The
signiﬁcance of differences between the means was determined by
Student's t-test.
Acknowledgments
We thank H. Murase and M. Tomiyama for their secretarial work.
This research was supported in part by grants-in-aid from the
Ministry of Health, Labor, and Welfare; the Ministry of Education,
Culture, Sports, Science, and Technology; and the Global Center of
Excellence Program.
References
Allain, F., Denys, A., Spik, G., 1996. Cyclophilin Bmediates cyclosporin A incorporation in
human blood T-lymphocytes through the speciﬁc binding of complexed drug to the
cell surface. Biochem. J. 317 (Pt 2), 565–570.
Almawi, W.Y., Melemedjian, O.K., 2000. Clinical and mechanistic differences between
FK506 (tacrolimus) and cyclosporin A. Nephrol. Dial. Transplant. 15 (12), 1916–1918.
Andreotti, A.H., 2003. Native state proline isomerization: an intrinsic molecular switch.
Biochemistry 42 (32), 9515–9524.
Bose, S., Mathur, M., Bates, P., Joshi, N., Banerjee, A.K., 2003. Requirement for cyclophilin
A for the replication of vesicular stomatitis virus New Jersey serotype. J. Gen. Virol.
84 (Pt 7), 1687–1699.
Carpentier, M., Allain, F., Haendler, B., Denys, A., Mariller, C., Benaissa, M., Spik, G., 1999.
Two distinct regions of cyclophilin B are involved in the recognition of a functional
receptor and of glycosaminoglycans on T lymphocytes. J. Biol. Chem. 274 (16),
10990–10998.
Castro, A.P., Carvalho, T.M., Moussatche, N., Damaso, C.R., 2003. Redistribution of
cyclophilin A to viral factories during vaccinia virus infection and its incorporation
into mature particles. J. Virol. 77 (16), 9052–9068.
Chatterji, U., Bobardt, M., Selvarajah, S., Yang, F., Tang, H., Sakamoto, N., Vuagniaux, G.,
Parkinson, T., Gallay, P., 2009. The isomerase active site of cyclophilin A is critical for
hepatitis C virus replication. J. Biol. Chem. 284 (25), 16998–17005.
Damaso, C.R.,Moussatche,N., 1998. Inhibitionof vaccinia virus replicationbycyclosporinA
analogues correlates with their afﬁnity for cellular cyclophilins. J. Gen. Virol. 79 (Pt 2),
339–346.
Davis, W.G., Blackwell, J.L., Shi, P.Y., Brinton, M.A., 2007. Interaction between the
cellular protein eEF1A and the 3′-terminal stem–loop of West Nile virus genomic
RNA facilitates viral minus-strand RNA synthesis. J. Virol. 81 (18), 10172–10187.
Emara, M.M., Brinton, M.A., 2007. Interaction of TIA-1/TIAR with West Nile and dengue
virus products in infected cells interferes with stress granule formation and
processing body assembly. Proc. Natl Acad. Sci. USA 104 (21), 9041–9046.
Fernandes, F., Ansari, I.U., Striker, R., 2010. Cyclosporine inhibits a direct interaction
between cyclophilins and hepatitis C NS5A. PLoS ONE 5 (3), e9815.
Franke, E.K., Yuan, H.E., Luban, J., 1994. Speciﬁc incorporation of cyclophilin A into HIV-
1 virions. Nature 372 (6504), 359–362.
Gaither, L.A., Borawski, J., Anderson, L.J., Balabanis, K.A., Devay, P., Joberty, G., Rau, C.,
Schirle, M., Bouwmeester, T., Mickanin, C., Zhao, S., Vickers, C., Lee, L., Deng, G.,
Baryza, J., Fujimoto, R.A., Lin, K., Compton, T., Wiedmann, B., 2010. Multiple
cyclophilins involved in different cellular pathways mediate HCV replication.
Virology 397 (1), 43–55.
Galigniana, M.D., Morishima, Y., Gallay, P.A., Pratt, W.B., 2004. Cyclophilin-A is bound
through its peptidylprolyl isomerase domain to the cytoplasmic dynein motor
protein complex. J. Biol. Chem. 279 (53), 55754–55759.
Ghosh, D., Basu, A., 2009. Japanese encephalitis—a pathological and clinical perspective.
PLoS Negl. Trop. Dis. 3 (9), e437.
Ho, S.N., Hunt, H.D., Horton, R.M., Pullen, J.K., Pease, L.R., 1989. Site-directed
mutagenesis by overlap extension using the polymerase chain reaction. Gene 77
(1), 51–59.
Karlas, A., Machuy, N., Shin, Y., Pleissner, K.P., Artarini, A., Heuer, D., Becker, D., Khalil, H.,
Ogilvie, L.A., Hess, S., Maurer, A.P., Muller, E., Wolff, T., Rudel, T., Meyer, T.F., 2010.
Genome-wide RNAi screen identiﬁes human host factors crucial for inﬂuenza virus
replication. Nature 463 (7282), 818–822.
Kaul, A., Stauffer, S., Berger, C., Pertel, T., Schmitt, J., Kallis, S., Zayas, M., Lohmann, V.,
Luban, J., Bartenschlager, R., 2009. Essential role of cyclophilin A for hepatitis C virus
replication and virus production and possible link to polyprotein cleavage kinetics.
PLoS Pathog. 5 (8), e1000546.
Kim, J., Choi, T.G., Ding, Y., Kim, Y., Ha, K.S., Lee, K.H., Kang, I., Ha, J., Kaufman, R.J., Lee, J.,
Choe, W., Kim, S.S., 2008. Overexpressed cyclophilin B suppresses apoptosis
associated with ROS and Ca2+ homeostasis after ER stress. J. Cell Sci. 121 (Pt 21),
3636–3648.
Konig, R., Zhou, Y., Elleder, D., Diamond, T.L., Bonamy, G.M., Irelan, J.T., Chiang, C.Y., Tu,
B.P., De Jesus, P.D., Lilley, C.E., Seidel, S., Opaluch, A.M., Caldwell, J.S., Weitzman, M.
D., Kuhen, K.L., Bandyopadhyay, S., Ideker, T., Orth, A.P., Miraglia, L.J., Bushman, F.D.,
Young, J.A., Chanda, S.K., 2008. Global analysis of host–pathogen interactions that
regulate early-stage HIV-1 replication. Cell 135 (1), 49–60.
Konig, R., Stertz, S., Zhou, Y., Inoue, A., Hoffmann, H.H., Bhattacharyya, S., Alamares, J.G.,
Tscherne, D.M., Ortigoza, M.B., Liang, Y., Gao, Q., Andrews, S.E., Bandyopadhyay, S., De
219H. Kambara et al. / Virology 412 (2011) 211–219Jesus, P., Tu, B.P., Pache, L., Shih, C., Orth, A., Bonamy, G., Miraglia, L., Ideker, T., Garcia-
Sastre, A., Young, J.A., Palese, P., Shaw, M.L., Chanda, S.K., 2010. Human host factors
required for inﬂuenza virus replication. Nature 463 (7282), 813–817.
Limjindaporn, T., Wongwiwat, W., Noisakran, S., Srisawat, C., Netsawang, J., Puttikhunt,
C., Kasinrerk, W., Avirutnan, P., Thiemmeca, S., Sriburi, R., Sittisombut, N., Malasit,
P., Yenchitsomanus, P.T., 2009. Interaction of dengue virus envelope protein with
endoplasmic reticulum-resident chaperones facilitates dengue virus production.
Biochem. Biophys. Res. Commun. 379 (2), 196–200.
Lindenbach, B.D., Rice, C.M., 1999. Genetic interaction of ﬂavivirus nonstructural
proteins NS1 and NS4A as a determinant of replicase function. J. Virol. 73 (6),
4611–4621.
Liu, X., Sun, L., Yu, M., Wang, Z., Xu, C., Xue, Q., Zhang, K., Ye, X., Kitamura, Y., Liu, W.,
2009. Cyclophilin A interacts with inﬂuenza A virus M1 protein and impairs the
early stage of the viral replication. Cell. Microbiol. 11 (5), 730–741.
Mackenzie, J.M., Jones, M.K., Young, P.R., 1996. Immunolocalization of the dengue virus
nonstructural glycoprotein NS1 suggests a role in viral RNA replication. Virology
220 (1), 232–240.
Mackenzie, J.M., Khromykh, A.A., Jones, M.K., Westaway, E.G., 1998. Subcellular
localization and some biochemical properties of the ﬂavivirus Kunjin nonstructural
proteins NS2A and NS4A. Virology 245 (2), 203–215.
Mackenzie, J.M., Jones, M.K., Westaway, E.G., 1999. Markers for trans-Golgi membranes
and the intermediate compartment localize to induced membranes with distinct
replication functions in ﬂavivirus-infected cells. J. Virol. 73 (11), 9555–9567.
Mackenzie, J.S., Gubler, D.J., Petersen, L.R., 2004. Emerging ﬂaviviruses: the spread and
resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat. Med. 10
(12 Suppl), S98–S109.
Mackenzie, J.M., Khromykh, A.A., Parton, R.G., 2007. Cholesterol manipulation by West
Nile virus perturbs the cellular immune response. Cell HostMicrobe 2 (4), 229–239.
Miller, S., Krijnse-Locker, J., 2008. Modiﬁcation of intracellular membrane structures for
virus replication. Nat. Rev. Microbiol. 6 (5), 363–374.
Miller, S., Kastner, S., Krijnse-Locker, J., Buhler, S., Bartenschlager, R., 2007. The non-
structural protein 4A of dengue virus is an integral membrane protein inducing
membrane alterations in a 2K-regulated manner. J. Biol. Chem. 282 (12), 8873–8882.
Mori, Y., Yamashita, T., Tanaka, Y., Tsuda, Y., Abe, T., Moriishi, K., Matsuura, Y., 2007.
Processing of capsid protein by cathepsin L plays a crucial role in replication of
Japanese encephalitis virus in neural and macrophage cells. J. Virol. 81 (16),
8477–8487.
Nakagawa, M., Sakamoto, N., Tanabe, Y., Koyama, T., Itsui, Y., Takeda, Y., Chen, C.H.,
Kakinuma, S., Oooka, S., Maekawa, S., Enomoto, N., Watanabe, M., 2005.
Suppression of hepatitis C virus replication by cyclosporin a is mediated by
blockade of cyclophilins. Gastroenterology 129 (3), 1031–1041.
Price, E.R., Zydowsky, L.D., Jin, M.J., Baker, C.H., McKeon, F.D., Walsh, C.T., 1991. Human
cyclophilin B: a second cyclophilin gene encodes a peptidyl-prolyl isomerase with a
signal sequence. Proc. Natl Acad. Sci. USA 88 (5), 1903–1907.
Price, E.R., Jin, M., Lim, D., Pati, S., Walsh, C.T., McKeon, F.D., 1994. Cyclophilin B
trafﬁcking through the secretory pathway is altered by binding of cyclosporin A.
Proc. Natl Acad. Sci. USA 91 (9), 3931–3935.
Puyang, X., Poulin, D.L., Mathy, J.E., Anderson, L.J., Ma, S., Fang, Z., Zhu, S., Lin, K.,
Fujimoto, R., Compton, T., Wiedmann, B., 2010. Mechanism of resistance of
hepatitis C virus replicons to structurally distinct cyclophilin inhibitors. Antimicrob.
Agents Chemother. 54 (5), 1981–1987.
Qing, M., Yang, F., Zhang, B., Zou, G., Robida, J.M., Yuan, Z., Tang, H., Shi, P.Y., 2009.
Cyclosporine inhibits ﬂavivirus replication through blocking the interaction
between host cyclophilins and viral NS5 protein. Antimicrob. Agents Chemother.
53 (8), 3226–3235.
Reyes-Del Valle, J., Chavez-Salinas, S., Medina, F., Del Angel, R.M., 2005. Heat shock
protein 90 and heat shock protein 70 are components of dengue virus receptor
complex in human cells. J. Virol. 79 (8), 4557–4567.Roosendaal, J., Westaway, E.G., Khromykh, A., Mackenzie, J.M., 2006. Regulated
cleavages at the West Nile virus NS4A-2K-NS4B junctions play a major role in
rearranging cytoplasmic membranes and Golgi trafﬁcking of the NS4A protein. J.
Virol. 80 (9), 4623–4632.
Rycyzyn, M.A., Clevenger, C.V., 2002. The intranuclear prolactin/cyclophilin B complex
as a transcriptional inducer. Proc. Natl Acad. Sci. USA 99 (10), 6790–6795.
Sadeg, N., Pham-Huy, C., Rucay, P., Righenzi, S., Halle-Pannenko, O., Claude, J.R.,
Bismuth, H., Duc, H.T., 1993. In vitro and in vivo comparative studies on
immunosuppressive properties of cyclosporines A, C, D and metabolites M1, M17
and M21. Immunopharmacol. Immunotoxicol. 15 (2–3), 163–177.
Silverman, J.A., Hayes,M.L., Luft, B.J., Joiner, K.A., 1997. Characterization of anti-Toxoplasma
activity of SDZ 215-918, a cyclosporin derivative lacking immunosuppressive
and peptidyl-prolyl-isomerase-inhibiting activity: possible role of a P glycoprotein in
Toxoplasma physiology. Antimicrob. Agents Chemother. 41 (9), 1859–1866.
Solomon, T., Ni, H., Beasley, D.W., Ekkelenkamp, M., Cardosa, M.J., Barrett, A.D., 2003.
Origin and evolution of Japanese encephalitis virus in southeast Asia. J. Virol. 77 (5),
3091–3098.
Sumiyoshi, H., Mori, C., Fuke, I., Morita, K., Kuhara, S., Kondou, J., Kikuchi, Y., Nagamatu,
H., Igarashi, A., 1987. Complete nucleotide sequence of the Japanese encephalitis
virus genome RNA. Virology 161 (2), 497–510.
Taguwa, S., Kambara, H., Omori, H., Tani, H., Abe, T., Mori, Y., Suzuki, T., Yoshimori, T.,
Moriishi, K., Matsuura, Y., 2009. Cochaperone activity of human butyrate-induced
transcript 1 facilitates hepatitis C virus replication through an Hsp90-dependent
pathway. J. Virol. 83 (20), 10427–10436.
Tai, A.W., Benita, Y., Peng, L.F., Kim, S.S., Sakamoto, N., Xavier, R.J., Chung, R.T., 2009. A
functional genomic screen identiﬁes cellular cofactors of hepatitis C virus
replication. Cell Host Microbe 5 (3), 298–307.
Tani, H., Shiokawa, M., Kaname, Y., Kambara, H., Mori, Y., Abe, T., Moriishi, K., Matsuura,
Y., 2010. Involvement of ceramide in the propagation of Japanese encephalitis
virus. J. Virol. 84 (6), 2798–2807.
Thali, M., Bukovsky, A., Kondo, E., Rosenwirth, B., Walsh, C.T., Sodroski, J., Gottlinger, H.
G., 1994. Functional association of cyclophilin A with HIV-1 virions. Nature 372
(6504), 363–365.
Wang, P., Heitman, J., 2005. The cyclophilins. Genome Biol. 6 (7), 226.
Watanabe, A., Yoneda, M., Ikeda, F., Terao-Muto, Y., Sato, H., Kai, C., 2010. CD147/
EMMPRIN acts as a functional entry receptor for measles virus on epithelial cells. J.
Virol. 84 (9), 4183–4193.
Watashi, K., Ishii, N., Hijikata, M., Inoue, D., Murata, T., Miyanari, Y., Shimotohno, K.,
2005. Cyclophilin B is a functional regulator of hepatitis C virus RNA polymerase.
Mol. Cell 19 (1), 111–122.
Wati, S., Soo, M.L., Zilm, P., Li, P., Paton, A.W., Burrell, C.J., Beard, M., Carr, J.M., 2009.
Dengue virus infection induces upregulation of GRP78, which acts to chaperone
viral antigen production. J. Virol. 83 (24), 12871–12880.
Welsch, S., Miller, S., Romero-Brey, I., Merz, A., Bleck, C.K., Walther, P., Fuller, S.D.,
Antony, C., Krijnse-Locker, J., Bartenschlager, R., 2009. Composition and three-
dimensional architecture of the dengue virus replication and assembly sites. Cell
Host Microbe 5 (4), 365–375.
Wu, S.F., Lee, C.J., Liao, C.L., Dwek, R.A., Zitzmann, N., Lin, Y.L., 2002. Antiviral effects of
an iminosugar derivative on ﬂavivirus infections. J. Virol. 76 (8), 3596–3604.
Yang, F., Robotham, J.M., Nelson, H.B., Irsigler, A., Kenworthy, R., Tang, H., 2008.
Cyclophilin A is an essential cofactor for hepatitis C virus infection and the principal
mediator of cyclosporine resistance in vitro. J. Virol. 82 (11), 5269–5278.
Zhang, J., Herscovitz, H., 2003. Nascent lipidated apolipoprotein B is transported to the
Golgi as an incompletely folded intermediate as probed by its association with
network of endoplasmic reticulum molecular chaperones, GRP94, ERp72, BiP,
calreticulin, and cyclophilin B. J. Biol. Chem. 278 (9), 7459–7468.
Zhang, L.,Mohan, P.M., Padmanabhan,R., 1992. Processingand localizationofDenguevirus
type 2 polyprotein precursor NS3-NS4A-NS4B-NS5. J. Virol. 66 (12), 7549–7554.
